Cargando…
Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
Patients with primary aldosteronism (PA) are more susceptible to cardiovascular disease and mortality than patients with primary hypertension. This is mostly attributed to excess production of aldosterone and its effects on the development of vascular injury. A novel functional test (T(50)) measures...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818752/ https://www.ncbi.nlm.nih.gov/pubmed/35141300 http://dx.doi.org/10.3389/fcvm.2022.771096 |
_version_ | 1784645898844766208 |
---|---|
author | Kantauskaite, Marta Bolten, Katharina Boschheidgen, Matthias Schmidt, Claudia Kolb, Thilo Eckardt, Kai Uwe Pasch, Andreas Schimmöller, Lars Rump, Lars C. Voelkl, Jakob Stegbauer, Johannes |
author_facet | Kantauskaite, Marta Bolten, Katharina Boschheidgen, Matthias Schmidt, Claudia Kolb, Thilo Eckardt, Kai Uwe Pasch, Andreas Schimmöller, Lars Rump, Lars C. Voelkl, Jakob Stegbauer, Johannes |
author_sort | Kantauskaite, Marta |
collection | PubMed |
description | Patients with primary aldosteronism (PA) are more susceptible to cardiovascular disease and mortality than patients with primary hypertension. This is mostly attributed to excess production of aldosterone and its effects on the development of vascular injury. A novel functional test (T(50)) measures serum calcification propensity. Lower T(50)-values predict higher cardiovascular risk. We investigated serum calcification propensity and vascular calcification in PA and resistant hypertension (RH). T(50) measurement was performed in patients with PA (n = 66) and RH (n = 28) at baseline and after 403 (279–640) and 389 (277–527) days of treatment. No significant differences in T(50)-values were observed between the groups (371 ± 65 and 382 ± 44 min, in PA and RH group, respectively, p > 0.05). However, higher aldosterone-to-renin ratios were associated with lower T(50)-values in PA-patients (r −0.282, p < 0.05). Furthermore, lower T(50)-values were associated with increased abdominal aortic calcification measured by Agatston score in PA (r −0.534, p < 0.05). In both, PA and RH, higher atherosclerotic cardiovascular disease (ACSVD) scores (r −0.403, p < 0.05) and lower HDL (r 0.469, p < 0.05) was related to lower T(50)-values in a linear regression model. Adrenalectomy or medical treatment did not increase T(50)-values. In comparison to patients with stable T(50)-values, PA patients with a decrease in T(50) after intervention had higher serum calcium concentrations at baseline (2.24 ± 0.11 vs. 2.37 ± 0.10 mmol/l, p < 0.05). This decline of T(50)-values at follow-up was also associated with a decrease in serum magnesium (−0.03 ± 0.03 mmol/l, p < 0.05) and an increase in phosphate concentrations (0.11 ± 0.11 mmol/l, p < 0.05). Resistant hypertension patients with a decrease in T(50)-values at follow-up had a significantly lower eGFR at baseline. In summary, these data demonstrate an association between a high aldosterone-to-renin ratio and low T(50)-values in PA. Moreover, lower T(50)-values are associated with higher ACSVD scores and more pronounced vascular calcification in PA. Thus, serum calcification propensity may be a novel modifiable risk factor in PA. |
format | Online Article Text |
id | pubmed-8818752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88187522022-02-08 Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism Kantauskaite, Marta Bolten, Katharina Boschheidgen, Matthias Schmidt, Claudia Kolb, Thilo Eckardt, Kai Uwe Pasch, Andreas Schimmöller, Lars Rump, Lars C. Voelkl, Jakob Stegbauer, Johannes Front Cardiovasc Med Cardiovascular Medicine Patients with primary aldosteronism (PA) are more susceptible to cardiovascular disease and mortality than patients with primary hypertension. This is mostly attributed to excess production of aldosterone and its effects on the development of vascular injury. A novel functional test (T(50)) measures serum calcification propensity. Lower T(50)-values predict higher cardiovascular risk. We investigated serum calcification propensity and vascular calcification in PA and resistant hypertension (RH). T(50) measurement was performed in patients with PA (n = 66) and RH (n = 28) at baseline and after 403 (279–640) and 389 (277–527) days of treatment. No significant differences in T(50)-values were observed between the groups (371 ± 65 and 382 ± 44 min, in PA and RH group, respectively, p > 0.05). However, higher aldosterone-to-renin ratios were associated with lower T(50)-values in PA-patients (r −0.282, p < 0.05). Furthermore, lower T(50)-values were associated with increased abdominal aortic calcification measured by Agatston score in PA (r −0.534, p < 0.05). In both, PA and RH, higher atherosclerotic cardiovascular disease (ACSVD) scores (r −0.403, p < 0.05) and lower HDL (r 0.469, p < 0.05) was related to lower T(50)-values in a linear regression model. Adrenalectomy or medical treatment did not increase T(50)-values. In comparison to patients with stable T(50)-values, PA patients with a decrease in T(50) after intervention had higher serum calcium concentrations at baseline (2.24 ± 0.11 vs. 2.37 ± 0.10 mmol/l, p < 0.05). This decline of T(50)-values at follow-up was also associated with a decrease in serum magnesium (−0.03 ± 0.03 mmol/l, p < 0.05) and an increase in phosphate concentrations (0.11 ± 0.11 mmol/l, p < 0.05). Resistant hypertension patients with a decrease in T(50)-values at follow-up had a significantly lower eGFR at baseline. In summary, these data demonstrate an association between a high aldosterone-to-renin ratio and low T(50)-values in PA. Moreover, lower T(50)-values are associated with higher ACSVD scores and more pronounced vascular calcification in PA. Thus, serum calcification propensity may be a novel modifiable risk factor in PA. Frontiers Media S.A. 2022-01-24 /pmc/articles/PMC8818752/ /pubmed/35141300 http://dx.doi.org/10.3389/fcvm.2022.771096 Text en Copyright © 2022 Kantauskaite, Bolten, Boschheidgen, Schmidt, Kolb, Eckardt, Pasch, Schimmöller, Rump, Voelkl and Stegbauer. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Kantauskaite, Marta Bolten, Katharina Boschheidgen, Matthias Schmidt, Claudia Kolb, Thilo Eckardt, Kai Uwe Pasch, Andreas Schimmöller, Lars Rump, Lars C. Voelkl, Jakob Stegbauer, Johannes Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism |
title | Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism |
title_full | Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism |
title_fullStr | Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism |
title_full_unstemmed | Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism |
title_short | Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism |
title_sort | serum calcification propensity and calcification of the abdominal aorta in patients with primary aldosteronism |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818752/ https://www.ncbi.nlm.nih.gov/pubmed/35141300 http://dx.doi.org/10.3389/fcvm.2022.771096 |
work_keys_str_mv | AT kantauskaitemarta serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT boltenkatharina serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT boschheidgenmatthias serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT schmidtclaudia serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT kolbthilo serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT eckardtkaiuwe serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT paschandreas serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT schimmollerlars serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT rumplarsc serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT voelkljakob serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism AT stegbauerjohannes serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism |